PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Sep-2023 Lundbeckfonden BioCapital and +ND Capital join forces: New investment in novel hormone-free fertility treatment for women Lundbeckfonden BioCapital
26-Sep-2023 MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications MC2 Therapeutics
26-Sep-2023 GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development B3C newswire
26-Sep-2023 Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases Evotec SE
26-Sep-2023 Polpharma Biologics Announces Approval of Europe’s First and Only Biosimilar for Multiple Sclerosis - Tyruko® (Natalizumab) B3C newswire
25-Sep-2023 Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma Eckert & Ziegler Strahlen- und Medizintechnik AG
25-Sep-2023 US FDA approves Jardiance® for the treatment of adults with chronic kidney disease Eli Lilly
25-Sep-2023 Cantourage Group SE: Cantourage shortlisted for European Small and Mid-Cap Awards 2023 Cantourage Group SE
25-Sep-2023 Cellbox Solutions Submits Device Master File (DMF) to the U.S. FDA Cellbox Solutions
25-Sep-2023 DEFENCE’S ACCUM®-mRNA LIPID NANOPARTICLES ELICIT ANTIBODY RESPONSE 2X STRONGER THAN STANDARD mRNA VACCINES Defence Therapeutics Inc.
25-Sep-2023 MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications B3C newswire
25-Sep-2023 Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101) Biophytis
25-Sep-2023 Kinarus Therapeutics has decided to file for bankruptcy Kinarus Therapeutics Holding AG
22-Sep-2023 Veranova Welcomes Dr. William Sanders as Global VP of Chemical Development Operations Veranova
22-Sep-2023 ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs The Institute of Cancer Research, London
22-Sep-2023 Arriello appoints experienced biotech expert, Kate Coleman, as VP of Quality & Compliance Arriello
22-Sep-2023 Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance Sunshine Biopharma
22-Sep-2023 Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023 Medacta Group SA
21-Sep-2023 Straumann Group acquires AlliedStar, an intraoral scanner provider in China Straumann Holding AG
21-Sep-2023 Abivax presents first-half 2023 financial results ABIVAX